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                     Introduction 
 
 
 
INTRODUCTION 
Tuberculosis (TB) is the most prevalent human infections and causes more deaths 
worldwide than any other infectious disease. Tuberculosis (TB) is the leading communicable 
disease among the ten cause of global mortality. It is caused by Tubercle bacillus, known as 
Mycobacterium tuberculosis, and more rarely Mycobacterium bovis whose host is human.
1
 
Tuberculosis is on the rise throughout the world. Better understanding and knowledge about TB 
remains an important tool in its control. 
2 
Estimates show that approximately one third of the global population is infected and 8 
million new cases of TB occur each year, leading to nearly 3 million deaths annually. The World 
Health Organization (WHO) reported that, TB is almost exclusively a disease of the developing 
countries.
3 
About 5,000 persons were infected per day, of which 95% are from developing 
countries.
1
 In India, almost 70% of TB patients are aged between 15 and 54 years. While 2/3 are 
male, TB takes a disproportionately larger among young females, with more than 50% of female 
cases occurring before 34 years of age, according to the Revised National TB Control 
Programme's (RNTCP) 2011 report. The direct and indirect cost of TB to India amounts to an 
estimated $23.7 billion annually. Studies suggest that on an average three months of work time is 
lost as a result of TB.
4 
According to World Health Organization (WHO), by the end of 2020, nearly one billion 
people will be newly infected, 200 million people will get sick and 35 million will die from 
tuberculosis, if control is not further strengthened. 
2 
Today, airborne M. tuberculosis is the main 
threat to humans which can produce either a silent, latent infection or a progressive active 
disease. Left untreated or improperly treated, TB causes progressive tissue destruction and 
eventually death. Drug treatment is the keystone of tuberculosis management. Once active 
disease is present, a bare minimum of 2 drugs and generally 3 or 4 drugs must be used 
simultaneously.
 
The duration of the treatment depends on the condition of the hosts, extent of disease, 
presence of drug resistance, and tolerance of medications. The shortest duration of treatment is 
generally 6 months, and 2 to 3 years of treatment is necessary for cases of multi drug resistance 
TB (MDR TB). As it is a long term treatment vigilant follow up is required to improve the 
treatment outcome. 
5 
 
Some more facts about TB: 
 
• There are 3, 00,000 new cases annually; 1, 37,000 are infectious, smear-positive cases;   
 
• The annual incidence of TB is 99 per 1, 00,000 population for smear-positive cases and 221 
per 1,00,000 for all forms;   
 
• TB causes 70,000 deaths per year;  
 
• The case detection rate is 41% (NTP, 2003);  
 
• The cure rate of detected cases under DOTS is 84% (with 3, 00,000 new cases annually, those 
cured comprise only 3.2% of all new cases);   
 
• Incidence is believed to be higher in densely populated urban areas with poor living 
Conditions.eg. overcrowding;   
• The female: male ratio is 2:5 among new smear-positive cases registered for treatment.3 
  
Every day in India, under the Revised Nation TB Control Programme, more than 15,000 
people are examined. Estimates suggest that two persons die every three minutes due to 
tuberculosis and 5,000 new TB cases are diagnosed per day. Three lakh children drop out from 
school due to TB-related problems in the family. Globally, one in every five new cases of TB 
comes from India; A single patient can infect 10-15 people in a year.
6 
Despite the availability of 
effective treatment, TB is still a major health problem in most of countries. The poor out-come 
was accredited to poor patient adherence, and to interruption partly due to adverse drug 
reaction (WHO, 1997).
3
 Non-compliance is cited as a major obstacle to the control of 
tuberculosis at the level of public health. It is also a serious problem in the treatment of 
individual patients and in the development of drug resistant strains. 
7 
Medication adherence or the older term, medication compliance, is defined as the extent 
to which a person‟s medication use behavior coincides with medical or health advice; and 
persistence as the duration of time from initiation to discontinuation of therapy. 
After several decades of research, we have learned that medication non-adherence is due 
to many factors including lack of adequate knowledge about medication and treatment goals, 
beliefs about the medication, complex regimens that are difficult to manage, side effects, and 
costs associated with medications.
8 
Weiguo X et al., conducted a study in Jiangsu region of China entitled as “Adherence to 
anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative 
study”, with the core objective to locate out the exacting barriers to and facilitators of patient 
adherence during TB therapy. For this quantitative study, seven hundred and eighty TB patients 
consecutively registered since 2006 in 13 counties (districts) were queried with a prearranged 
questionnaire. There are almost 16 factors described which leads to the non adherence for the TB 
treatment. Majority of them are due to the lack of knowledge about the importance of the 
completion of therapy which includes, Symptoms have been relieved and it is not necessary to 
continue treatment (26.83%), Treatment course is too long and the dose is too large (15.85%), 
treatment is not necessary as I am so old (8.54%), I worry about my body damaged by anti-
tuberculosis drugs (15.85%). One of the most vital stuff which associated to our study was, out 
of these 16 factors 37.80% (which is the uppermost percentage) of patients were non adherent 
due to the severe ADRs. From this study it was come across that the lack of knowledge about the 
treatment and ATT induced ADRs are the two major factors which leads to the patient‟s non-
adherence to the TB therapy. The study accomplished that more magnitude should be given to 
treatment adherence under the current TB control program. Also more patient centered 
interventions and superior concentration to structural barriers are needed to improve treatment 
adherence.
9 
According to World Health Organization, the reasons for poor adherence with anti-
tuberculosis chemotherapy in developing countries are complicated. That includes; the 
characteristics of the individual patient, communication between the patients and healthcare 
providers, social and economic factors such as the availability of drugs, duration and number of 
medications needed, side effects, cost of treatment, competing demands on time, contradictory 
norms or expectations of families and cultural groups as well as poor quality of the tuberculosis 
control infrastructure (WHO, 2006). However, patient adherence to tuberculosis treatment 
requires the active participation of the patient in self management of treatment and cooperation 
between the patient and the health care provider.  
All healthcare providers need to counsel TB patients not only on the importance of taking 
their drugs regularly but also on the importance of completing their course of treatment. Poor 
adherence with tuberculosis treatment is more dangerous than no treatment as it may increase the 
risk of developing multi drugs resistant tuberculosis strains (MDR-TB).
1 
 
The failure to take prescribed medication is a universal perplexing phenomenon. This fact 
must be taken into consideration when one endeavors to treat a patient or control diseases in a 
community. TB is a communicable disease requiring prolonged treatment, and poor adherence to 
a prescribed treatment increases the risk of morbidity, mortality and spread of disease in the 
community.
10 
Current anti-tuberculosis therapy consists of a cocktail of drugs taken over a period of at 
least 6 months for new patients and 8 months for retreatment patients. Because of this long 
duration of the therapy, there is a risk of treatment interruption or default, an experience that 
contributes to prolonged infectiousness, drug resistance, relapse and death. Efforts to improve 
treatment outcomes require a proper understanding of particular barriers to and facilitators of 
patient's adherence.
9 
 
FACTORS ASSOCIATED WITH ADHERENCE TO TREATMENT 
 
Patient related factors The evidence between demographic characteristics such as age, race, 
gender, educational level, and socioeconomic status is inconsistent. 
However, certain other patient-related variables have been associated with adherence behavior. 
These include: 
• Awareness about treatment regimens 
• Patient perception of profit derived from treatment and barriers to treatment 
• Socio-demographic factors, including homelessness, mental illness, lack of communal support, 
and higher number of life stressors 
• Specific cultural beliefs about medication taking, disease spread and disease progression which 
can also influence medication-taking behavior. 
 
Provider characteristics may influence the quality of patient-physician relationships and thus 
have an impact on patient behavior. In particular: 
• The quality of physicians‟ interpersonal skills has been shown to affect adherence 
• Positive outcomes may be more likely when physicians make efforts to explain treatment 
regimens and address patient concerns 
• Non adherence has been noted increasingly in situations where physicians appear insensitive, 
use medical terminology, view patients as complainer, or do not provide clear messages about 
the cause of the illness or reasons for treatment. 
Clinic facilities affect patients‟ access to care and therefore can impact on compliance. 
Important factors that may get in the way of adherence are: 
• Long waiting times before appointments 
• Inconvenient clinic timing. 
• Lengthy delays between initial visit and follow up reviews. 
• Substantial travel expenditure. 
  
 
Characteristics of treatment regimens can also affect patients‟ ability and willingness to 
adhere to them. Adherence has been shown to decrease with an increase in: 
• Number of medications, frequency of dosing, and complexity of regimen 
•Duration of regimen. 
• Adverse drug reactions. 
• Special instructions, such as dietary change 
 
Disease characteristics have also been shown to influence adherence. Non adherence may be 
more common among patients with: 
•Chronic illness rather than acute illness 
•Greater disability created by the disease 
• Resolution of disease symptoms, because patients who are no longer symptomatic feel that they 
don‟t have to continue the medications .11 
The World Health Organization (WHO) defines an adverse drug reaction (ADR) as any 
response to a drug which is noxious and unintended, and which occurs at doses normally used in 
man for prophylaxis, diagnosis or therapy of disease, or for the modification of physiological 
function. 
12 
ATT exhibits greater level of efficacy with a satisfactory degree of toxicity; however 
combination treatment may produce severe adverse events. Important adverse effects are 
hepatitis, join pain, skin rash, gastro intestinal upset (nausea/vomiting/GI upset), hyperuricemia, 
Constipation, peripheral neuropathy, and visual disturbances. 
According to World Health Organization (WHO)   the poor out-come was attributed to 
poor patient compliance, to primary multidrug resistance and to interruption partially due to 
ADR (WHO 1997). TB hampered with poor patient compliance and intolerance at least  partially 
due to the ADRs134 (26%) out of 519 TB patients from the study of Schaberg T et al., were 
discontinued therapy due side effects.
13 
The influence of side effects – real, anticipated or interpreted on compliance to treatment 
was mentioned in a number of studies. Some patients reported stopping medication due to 
adverse effects while others complained that they were not educated about side effects and what 
to do to counter those.
14 
 
In-depth interviews among both TB patients and local doctors point out that ADR is a 
motive for treatment non-adherence. Worry of the risks of ADRs leads some TB patients to 
break off the treatment. Local health workers often cannot find out this discontinuation of 
treatment due to the lack of an ADR surveillance system under the current DOTS program. 
 
"The majority of TB patients in my village have good adherence to treatment. However, 
some patients are reluctant to cooperate with us. The main reasons are the adverse reactions 
and long course of treatment. For example, one patient didn't visit my clinic to take drugs as 
regularly. So I called him immediately. He told me that he didn't want to continue as he felt much 
more uncomfortable after taking drugs." (Doctor) 
9 
 
“… I don’t want to take these pills, because they make me sick, they hurt me…” (Female TB  
patient, Bolivia)
14 
Anupa KC et al., evaluated the rate of ADR during DOTS treatment for a period of 5 
months at the Regional Tuberculosis Center (RTC) in Pokhara, Western Nepal. Totally 137 
patients were included in the study, amongst 54.74% (n=75) of patients reported occurrence of 
ADRs. The study concluded that, it is fundamentally required a system for proper monitoring of 
ADRs due to anti tubercular drugs. Counseling of patients for timely hindrance, revealing and 
management of ADRs was also highly suggestive.
15 
 
 
 
 
 
 
ROLE OF PHARMACIST IN ATT- AS A PART OF HEALTH CARE TEAM 
 
Patients understanding of their treatment regimen can influence their adherence behavior. 
Therefore, patient education can be awfully effectual response to many of the difficulties in 
getting patients to adhere to a complete course of TB therapy Adherence to treatment may be 
best understood as a set of interrelated behaviors that includes cognitive formulation of a 
personal understanding of why pharmacotherapy is prescribed; interpersonal skills to 
communicate effectively with health care providers; and practical skills related to medication 
taking.
16 
The long term treatment period was poorly understood by patients and adherence seems 
to be facilitated where patients understood the importance of completing treatment. 
Since knowledge plays an important role in patient compliance, the implementation of education 
programme can enhance the treatment outcome.
14 
              Here comes the role of pharmacist. Clinical pharmacist has the responsibility to identify, 
prevent and resolve medication related problems. The services given by the clinical pharmacist 
include medication history interview, medication order review, providing drug information, 
prevention, assessment and management of drug interaction, patient medication counseling and 
management of ADRs which will improve patient compliance and reduce health care costs.
17 
The pharmacist should educate patients on the importance of continuing their 
chemotherapy despite symptomatic improvement. Pharmacists should become a part of 
multidisciplinary band (with nurses, physicians, social workers) devoted to successful 
chemotherapy of TB patients and their families.
5 
 
The pharmacotherapy approach to the treatment of tuberculosis revealed that majority of 
the patients took their drugs according to instructions given by either the pharmacists or 
physician‟s education was significantly associated with drug adherence. This corroborates with 
the study of Fakeye et al. (1997) who reported that patients‟ adherence with instructions was 
significantly affected by education. This shows that the more educated a patient is, the better 
understanding of the disease state and comprehension of instructions given on drug usage, and 
these could enhance adherence. On nausea and vomiting side effects experienced by the patients, 
(Fakeye et al., 1997) also suggested that the healthcare providers especially the pharmacists 
should emphasize always on the specific times the drug is to be taken in relation to meals. In 
spite of this, very rare adverse reaction on hepatotoxicity induced by pyrazinamide was recorded 
in few (0.7%) of the patients during personal interview. With respect to improvement in the 
health condition, majority of the patients realized that they felt much better while taking their 
medications strictly. Patients that take their medications in an irregular and unreliable manner are 
at high risk of treatment failure, relapse and development of drug-resistance TB strains.
1
 
Moadebi S et al., conducted a study entitled as “Patient Satisfaction with Anti 
tuberculosis Medication Counseling: A Comparison of Services Provided by Pharmacists and 
Nurses” with core objective to evaluate patient satisfaction as an important method of measuring 
the quality of pharmaceutical services. From this study, it was evident that, compliance to 
treatment requires the active participation of the patient in self-management of management and 
cooperation between the patient and the health care providers. The reasons for non adherence are 
complex, and include lack of knowledge about medications and their side effects. Pharmacists 
who dispense anti tuberculosis medications provide counseling to enhance patients‟ 
understanding of why they are taking the medication and the potential side effects of treatment, 
thereby helping to guarantee patient adherence. The pharmacist‟s role in advocating patient 
compliance is important for eradicating disease and for preventing relapse and development of 
resistant strains. 
Patients counselled by pharmacists were more likely to be very satisfied with information 
provided about adverse effects As well, patients found the written information provided by 
pharmacists more meaningful when used in conjunction with the pharmacist‟s counseling 
The patients demonstrated a high level of knowledge of their medication regimens, which 
illustrates the benefit of additional support provided by pharmacists. These results are consistent 
with results from previous studies showing that pharmacist intervention improves patients‟ 
ability to recall their medication and increases patients‟ knowledge of side effects after 
medication counselling. In addition, the pharmacist‟s involvement in the TB counseling program 
has been beneficial in ensuring that drug histories are more accurate and complete.
18 
           Considering all the above aspects, a patient information pamphlet was introduced in the 
Pulmonology department and the study entitled “Effectiveness of Knowledge based approach for 
the improvement of patient adherence and reducing the severity of Adverse Drug Reaction in 
Anti Tubercular Therapy” was carried out. Both the physician and clinical pharmacist were 
equally participated to improve the enhanced therapeutic outcome in TB therapy by aiming the 
complete patient care. A thorough education by the pharmacist regarding the treatment and drugs 
and the possible adverse drug reactions were given. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
         Review of Literature 
 
 
 REVIEW OF LITRATURE 
An evaluation study for the drug adherence amongst TB patients in the University of 
Ilorin Teaching Hospital, Ilorin, Nigeria, was carried out by Bello SI and Itiola OA.
1
 Totally 
two hundred and eighty patients enrolled in this study of which 166 were males and 114 were 
females who received structured questionnaires. Study reported that there is an association 
between education and patients‟ adherence to their medications. Age has no significant 
association with patient‟s drug adherence, whereas education was significantly linked with 
patient‟s drug adherence Positive effect of counseling on the patient‟s adherence to their 
medications was also recorded.  
 
Erhabor G.E et al.,
7
 carried out a retrospective study to explore the impact of directly 
observed therapy (DOT) on patient adherence and the factors influencing it, at Chest clinic of 
Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria. Totally 199 
patients comprising 91 males and 108 females, were seen during the study period .They were 
mostly between the ages of 16 years and 45 years. From this, 73% complied and all of them were 
cured. The only factor that significantly influenced rate of compliance was closeness to the chest 
clinic. The study concluded as the Non-adherence is cited as a major obstacle to the control of 
tuberculosis and the DOTS therapy improves the rate of adherence. 
 
Mahmood I et al.,
3
 carried out a prospective randomized case study among 62 patients  
diagnosed as pulmonary tuberculosis patients, who receiving category I anti-TB drug treatment 
regimen in the DOTS providing centers during the period of July 2004 to July 2006. Category I 
comprised of 4 drugs (Rifampicin, Isoniazid, Ethambutol, Pyrazinamide) combination patients 
treated for initial 2 months, serum alanine aminotransferase levels were estimated at the first and 
fourth week of the treatment. 14(22.58%) patients were found to have no significant change, 
34(54.84%) patients had their levels in the upper limits, 13(20.97%) patients had their levels in-
between the upper limit and twice of the upper limit, while only 1(1.6%) patient crossed the level 
twice the upper limit. Study also found that the different types of unwanted effects due to ATT 
which are Nausea 43 (69.35%), Vomiting 4 (6.45%), Anorexia 32 (51.61%), Abdominal pain 
3(4.84%) and Jaundice. In our study the 4 FDC regimen was found to be well tolerated. Still 
close follow-up, early recognition, and the immediate withdrawal of the causative agent are vital 
to prevent progression and allow the liver to heal. This topic is of broader importance in the 
developing countries where both TB and liver diseases are endemic. 
 
A systematic review of qualitative research study were performed by Munro SA et al.,
14
 
to understand the factors considered by patients, caregivers and health care professional in 
contributing to TB medication adherence. Authors searched 19 electronic databases (1966–
February 2005) for this qualitative study. Study described that adherence to the lengthy course of 
TB treatment is a multifaceted, dynamic phenomenon with a wide range of factors impacting on 
treatment-taking behavior. Patient‟s compliance to their medications was influenced by a number 
of factors which include personal characteristics, treatment side effects, financial burden of TB 
Treatment and awareness, Attitudes, and Beliefs about TB Treatment. Some patients reported 
that they stopped medication because of adverse effects of TB drugs. The result of this review 
promoting that more patient-centered intervention, and more attention to structural barriers, were 
needed to improve treatment adherence for reducing the global disease burden attributable to TB. 
Jaggarajamma K et al.,
10
 conducted a study to elicit reasons for treatment default from 
a cohort of 186 TB patients under RNTCP and their DOT providers. From the study population 
16 had completed treatment, 25 died after defaulting, and 4 could not be traced. The study find 
out that main reasons for non-compliance among the TB patients were: drug related problems, 
migration, relief from symptoms, employment related, alcohol consumption, treatment from 
other centers, respectively. The study concluded that intensifying motivation and counseling of 
this group of patients are likely to improve their compliance and reduce default. 
Moadebi S etal.,
18
 conducted a comparison study named Patient Satisfaction with  
antituberculosis Medication Counselling: A Comparison of Services Provided by Pharmacists 
and Nurses. Patients counselled by pharmacists were more likely to be very satisfied with 
information provided about adverse effects As well, patients found the written information 
provided by pharmacists more meaningful when used in conjunction with the pharmacist‟s 
counseling. The patients demonstrated a high level of knowledge of their medication regimens, 
which illustrates the benefit of additional support provided by pharmacists. These results are 
consistent with results from previous studies showing that pharmacist intervention improves 
patients‟ ability to recall their medication and increases patients‟ knowledge of side effects after 
medication counselling. In addition, the pharmacist‟s involvement in the TB counselling 
program has been beneficial in ensuring that drug histories are more accurate and complete. 
Lee JIA and Hyun JC
19
 carried out a retrospective study to determine the prevalence of 
drug resistance and risk factors of drug resistance in patients with tuberculosis and to evaluate 
the clinical characteristics and socioeconomic status of patients with drug resistant tuberculosis. 
Drug susceptibility test and clinical and socioeconomic records for 308 cases of culture positive 
mycobacterium tuberculosis infection, diagnosed from March 1995 to February 2000 were 
included in the study. DR at least one drug was identified in 75(24.4%). DR group shows lesser 
adherence to adherence than drug sensitivity group. Drug resistant group showed more frequent 
self-interruption of medication, lower completion rate of therapy, and higher failure rate of 
follow up than the drug sensitive group. The study concluded that previously treated TB is a 
most important risk factor for DR. DR group especially acquired DR showed less compliance 
with treatment. The study recommending that more proper education and attention to prevent 
self-interruption should be given to a previously treated group. 
A qualitative and quantitative study on adherence to anti-tuberculosis treatment among 
pulmonary tuberculosis patients were conducted by Weiguo X et al.,
9
 in which 780 sputum-
smear positive TB patients in 13 districts were queried with a structured questionnaire. The study 
revealed that the risk of non-compliance was lower among patients who was  under DOTS by 
village doctors or regular home visits by health workers. Finally study concluded that more 
importance should be given to treatment adherence under the current TB control program. High 
financial burdens, lack of social support, ADRs and personal factors are associated with non-
adherence. In which about 37.80% of patients are non-adhere due to severe ADR and which is 
the primary reason when compare to other reasons for non-adherent during ATT 
A Meta-analysis of Prospective Studies was performed by Lazarou J et al.,
20
 to estimate 
the incidence of serious and fatal ADRs in hospital patients by searching through four electronic 
databases from 1966 to 1996. The overall incidences of serious ADRs in hospitalized patients 
were found to be 6.7%. Thus, they deduced that ADRs would rank from the fourth to sixth 
leading cause of death. 
 
Schaberg T et al.,
13
 conducted a study to determine the incidence of side effects severe 
adequate to cause intolerance of standard ATT with rifampin, isoniazid and pyrazinamide in 
patients hospitalized as a result of PTB. 519 patients with proven PTB, who initially received 
standard ATT, were retrospectively studied in a chest hospital. Final termination of rifampin, 
isoniazid or pyrazinamide because of severe side-effects was necessary in 23% patients. The 
most severe side effects leading to final termination of one drug were hepatotoxicity (11%), 
exanthema (6%), and arthralgia (2%). Pyrazinamide showed more side effects with15% than 
isoniazid with 7% and rifampin with 1.5%. The study concluded that the side-effects of standard 
ATT are frequent in hospitalized patients aged ≥60 yrs or with a history of hepatitis, and are 
possibly due to pyrazinamide rather than to isoniazid or rifampin 
Khalid M et al.,
21
 carried out a prospective cohort study at Civil Hospital Karachi from 
July 2004 for one year to evaluate the severity and frequency of liver toxicity caused by  ATT  
and to evaluate whether concurrence of risk factors influence the Antituberculosis drug induced 
liver toxicity. A total of three hundred and thirty nine patients diagnosed of active tuberculosis 
with normal pretreatment hepatic function were monitored clinically as well as biochemically. 
ATT induced liver toxicity was observed in 67 (19.76%) out of three hundred and thirty nine 
patients. Females were more prone to TB when compared to males (26.3% vs. 19.7%). Factors 
such as alcohol, paracetamol and low levels of serum cholesterol were proved as predisposing 
factors. It was found that most of the patients, 61%, developed the liver toxicity within 2 weeks 
of starting ATT with mild to moderate change in ALT and AST. Study concluded that ATT 
induced liver toxicity is significant and can cause permanent injury and death. Early detection 
with immediate removal of causing agent is most important factor to arrest its development and 
allow liver to heal. 
 
By conducting a descriptive study, Habib-ullah K et al.,
22
 evaluated the occurrence of 
drug induced liver injury during anti-tuberculosis therapy from July 2007 to June 2008, at 
Medical Specialist Clinic, Pakistan. The purpose of this study was to determine its frequency, 
management and outcome of ATT induced liver injury. Study found that among 250 patients 
with tuberculosis, 25(10%) developed drug induced liver injury. Time interval between start of 
therapy and onset of symptoms was 6-120 days. ALT ranged from 80-435U/L. After stopping 
hepatotoxic drugs, ALT normalized in 2-10 weeks. 
A 5 month period study was performed by Anupa KC et al.,
15
 to determine the ADRs 
occurring during DOTS therapy and to assess their causality; severity and predisposing factors at 
the Regional Tuberculosis Center (RTC) in Pokhara, Western Nepal. Totally 137 patients 
included, among that 54.74% (n=75) reported occurrence of ADRs. Almost 24 types of ADRs 
were experienced which includes Tingling and burning sensation in hands and feet (11.03%), 
Joint pain (10.34), Dermatological manifestations (10%) and Anorexia / Nausea /Vomiting 
(9.66%). The study highlighting that there is a need of a system for proper monitoring for ADRs 
due to antitubercular drugs. Counseling of patients for timely prevention, detection and 
management of ADRs was also highly suggestive through this study. 
Kheirollah G et al.,
23
 performed a study to assess the rate of ADR induced by ATT 
drugs in the infectious disease department of a hospital at Iran for a period of one year. During 
the study time, total 83 patients received ATT; of them forty four patients developed at least one 
ADR. A total of 81 ADRs was detected in this study. ADRs were recognized as the major cause 
of hospitalization in 11 (13.3%) patients. The most frequent organ affected by ADRs was Liver 
and biliary system (37%). Hepatitis was observed in 25.3% patients causing to death in two 
patients. The study concluded that ATT drugs could cause significant ADR which will lead to 
hospital admissions, prolonged hospital stay or even death. So that more attention was need to 
prevent these reactions. 
Jasmin J et al.,
24
 analyzed the factors associated with drug resistance in tuberculosis by 
doing a prospective study. It is found that treatment default was the most important factor 
associated with drug resistance. Travel to different places, relief in symptoms, cost of the 
treatment and adverse drug effect were observed the reasons for default. The study concluded 
that drug resistance is a major problem in the control of tuberculosis. Its initiate should be 
controlled by scrupulously monitoring and ensuring patient compliance. 
Ali KK and Naushaba M
2
 performed a cross-sectional survey study to assess the level 
of knowledge about tuberculosis among 204 subjects. Data was collected through a pre-tested 
structured questionnaire which comprised of socio-demographic variables and questions about 
cause, transmission, common clinical features and cure of tuberculosis. Only 39% of study 
subjects knew that tuberculosis is an infectious disease, 19% reported that there is an 
asymptomatic stage of infection, 33% said that it is curable with proper treatment while 51% 
considered tuberculosis as a preventable disease. This study concluded that majority of study 
subjects had poor knowledge about tuberculosis, its prevention and magnitude. Proper 
knowledge and education about tuberculosis is vital to deal the challenge of this devastating 
disease 
 
Bhatt CP et al.,
25
 conducted a prospective study included 300 diagnosed cases of PTB 
who were attending the DOTS programme of Nepal to assess their knowledge about 
tuberculosis. The study found that most of the patients had satisfactory knowledge regarding the 
signs and symptoms of TB but their knowledge regarding causative agent for TB, disposal 
method for body fluids and sputum and preventive method for tuberculosis was still low. The 
authors recommended that National tuberculosis control authority should design health education 
programme. Such awareness campaign will increase the patient‟s general awareness about the 
disease and will aid to reduce transmission of disease, prevent DR cases and improve the 
efficacy of DOTS programme. 
Purohit SD et al.,
26
 conducted a pilot study between January and June 1986 to determine 
the awareness about tuberculosis among 1000 from different walks of life. 3 sets of questions 
pertaining to general aspects, diagnosis and treatment and preventive aspects of TB were 
introduced to general population to assess the extent of their knowledge about tuberculosis. From 
the study it is found that general knowledge about tuberculosis was poor in illiterate and low 
socio-economic population and high in literate and high socio-economic group. And finally the 
study extracted that, what is required at this stage it is necessary need a systematic, simple and 
regular programme for educating public about tuberculosis 
Valiev R et al.,
27
evaluated the awareness about TB and attitude towards therapeutical 
process among the patients at tuberculosis dispensaries by performing a survey study using the 
questionnaire. The survey indicated that as high as 2.3% of the patients with tuberculosis gave 
right answers to all the questions of a questionnaire. 61.8% of the respondents answered the bulk 
of the questions. The latter can be considered to be aware of their disease. The persons who are 
unaware of TB are more commonly males with a below-secondary literacy level, patients above 
50 years, and the unemployed. More than fifty percentages of such patients are not having the 
confident that they will be able to recover,which makes them refuse treating. The study 
concluded that a better awareness can improve the results of treatment and the outcomes of the 
disease. 
 
Whalen C C et al.,
28
 performed a trial in 2736 patients with HIV-infection in Kampala, 
Uganda to evaluate the three regimen to prevents TB  in adults infected with HIV. with positive 
tuberculin skin tests  with purified protein derivative (PPD) were randomly assigned to 1 of 4 
regimens: placebo, isoniazid daily for six months,  isoniazid, rifampin, and pyrazinamide daily 
for three months or isoniazid and rifampin daily for three months,. Subjects with anergy were 
randomly assigned to be given either placebo or six months of isoniazid. The medicine was 
dispensed monthly and was self-administered. And they concluded as for PPD-positive, HIV-
infected adults a six-month course of isoniazid confer short-term protection against tuberculosis. 
Multidrug regimen with isoniazid and rifampin taken for 3 months can also be used to reduce the 
risk of tuberculosis. 
 
A cross-sectional study on patients receiving DOTS regimen was conducted by Bagchi S 
et al.,
29
 at Mumbai, India. To determine the poor adherence with ATT among PTB patients.  Of 
the 538 patients, 84% were adherent to the treatment and 16% were non adherent. Men were 
more likely to be non adherent than women. Smoking during treatment and travel-related 
expenditure factors were considerably associated with non-compliance in the newly-diagnosed 
patient. The study concludes that proper counseling, life style modification and motivating the 
patient to come to clinic and taking medication is important to complete the therapy.  
 
Ansari M S et al.,
30
 conducted a  Cross sectional study on The role of socio-economic 
factors responsible for non-compliance of directly observed treatment short-course (DOTS) 
among Tuberculosis Patients,  Interviewed using a set of questionnaire at an institution at New 
Delhi, India. Patients who interrupted treatment for more than 2 months consecutively were 
classified as non-compliance cases. Total 80 patients were entered in the study out of that 69% 
were males and 31% were females. Out of this 80 patients, 85% of patients believed that anti 
tuberculosis drugs are bad to their health. Similarly 87% believed to stop ATT as soon as the 
symptoms disappeared. Their behavior for dropping number of tablets per dose daily was noted 
and found that 95 % of non-adherent patient agree to do so and only 5 % have taken full dose for 
whole period. It was found that male sexual category have more noncompliance majority of 
treatment defaulter were from 31-45 years. The study did not find much role for the socio-
economic factors for non adherence in ATT, but still the major hurdle was found to be the 
education, income and occupation.  
 
A Literature review study on Adherence to tuberculosis care in Canadian Aboriginal 
populations was done by Orr P
31
 in the year 2010. A systematic search and analytic review 
studies was undertaken, including an online electronic databases search and governmental and 
non-governmental agencies‟ publications. The study states that the poor adherence to therapy is 
the most common cause of treatment failure in tuberculosis. Adherence to the TB care is 
necessary for both the patient as well as the society. The International Standards for Tuberculosis 
Care and the Patients Charter outline the responsibilities for compliance on the part of both 
patients and providers. The use of directly observed programs provides the most reliable and 
accurate information about adherence, provided that the treatment is indeed observed. Patient 
self report of adherence is not consistently reliable. The study also pointed out some of the 
barriers of the non adherence in the TB care, following are some of them, (1)Health system 
factors, for example long waiting time to meet the physician, unclean clinics, lack of trust, 
respect or dignity in relationship between patients and health care workers, Staff that are 
insufficiently knowledgeable or skilled in the diagnosis, investigation and management of TB, 
particularly the potential side effects and toxicity of therapy etc., (2) personal factors such as; 
Knowledge, attitudes and beliefs, Co-morbidities and life stressors, Social factors like poverty, 
Social stigma, and  Self and community efficacy. This study concludes that the compliance 
behavior is influenced by complex interactions between health system, personal factors and 
societal factors, rather than directly from individual factors acting independently. 
 
A qualitative study at Ethiopia on Barriers in the management of TB treatment by 
Sagbakken M etal.,
32
 in 2007 reports that Non-adherence to ATT is an important obstruction for 
Tuberculosis control programs because non-adherence to treatment may results in extended 
infectiousness, DR, relapse, and death. They found that in-depth interviews during different 
stages of ATT were the most appropriate method to explore how context-specific enablers and 
barriers interact over time. During the study they found that unemployment led to a chain of 
interconnected barriers for most TB patients. Lack of income during the treatment, cost of the 
therapy and noncooperation from the family or friends made patients more vulnerable to non-
adherence. So the study concludes that the Interventions to facilitate compliance to ATT need to 
address both local factors and time-specific factors.   
 
A Retrospective study on factors associated with mortality in patients with drug-
susceptible PTB” by Nahid P et al.,33 from 1990-2001 was carried out. In which 565 patients 
were included according to the inclusion criteria, of which 37 patients died in the study period. 
Of this 37 deaths, 12 (32.4%) had Tuberculosis listed as contributing factor. From the study it 
was evident that the advanced age, non adherence and HIV co-infection of which non adherence 
primarily contributes to death. Thus improving adherence during early TB treatment may 
improve tuberculosis outcomes with decrease mortality. 
 
 
Martinson N A et al.,
34
 conducted a study about “New Regimens to Prevent 
Tuberculosis in Adults with HIV Infection” at Johns Hopkins Medicine and the University of the 
Witwatersrand, South Africa From September 2002 through June 2005. In this study 1150 
patients were included. Of these 1150 patients, 215 patients were receiving antiretroviral therapy. 
The most common reasons for stopping the treatment were non adherence, antiretroviral therapy 
and pregnancy. In their study, almost 90% of HIV patients completed treatment. In summary, 
rifamycin-based preventive treatment had similar efficacy to 6 months of isoniazid in tuberculin-
positive adults infected with HIV. In preventing reactivation of and re-infection with 
M.tuberculosis continuous treatment with isoniazid may be effective.  
 
A cross-sectional study was conducted in Agra, India on Noncompliance to DOTS: How 
it can be decreased by Chhaya Mittal and SC Gupta
35
 in 2009. A total of nine hundred patients 
were included in the study. Patients who were dropped out of ATT were further traced and 
interviewed thoroughly to find out the reasons of stopping and other associated factors. In the 
present study, 45.4% patients were adherent with the treatment and 26.2% were confirmed cured. 
On analyzing the reasons of default, ADRs were found to be the most frequent reason (43.2%). 
Next important reasons were feeling better and lack of time (14.4% & 13.5%) respectively. 
Alcoholism, going out of station, domestic problems  etc were also found to have more influence 
in defaulting the treatment. Non-adherence was found to be due to adverse effects of medicines, 
lack of time, and unawareness. So proper education to the patients about various aspects of TB 
medication and some measures to decrease side effects is of utmost importance. 
 
 
Liefooghe R et al.,
36
 carried out a randomised trial of the impact of counselling on 
treatment adherence of tuberculosis patients in Sialkot, Pakistan to find out the impact of 
counselling for the TB patients. Total 1019 patients were included in the study and out of that 49 
% patients were assigned in the intervention group and 51% to the control group. Counseling 
was given to the interventional group in different ways including the hospitalized patients. The 
control group got the usual care from the hospital. And the out come was measured on the basis 
of default from the therapy. There was a default rate of 54% in the control group where as in 
interventional group it was 47%. The impact of counseling was stronger on women patients than 
male patients. Thus the study suggests that counseling has a significant impact on the TB 
treatment.  
 
Pirmohamed M et al.,
37
 conducted a prospective observational study to ascertain the 
burden of ADRs through a prospective study of all admissions to hospital from Nov 2001 to Apr 
2002 in two hospitals in Merseyside. It shows that 1225 admissions related to an ADR, giving a 
prevalence of 6.5%, with the ADR directly leading to the admission in majority of cases. 
 
Marra F et al.,
38
 examined the incidence of major Adverse Drug Reactions and risk 
factors linked with first-line ATT through a study in which  Adverse drug reactions and its  
association with first-line ATT drug regimens. This study analyzed patients under treatment for 
active TB from a population-based database during 2000–2005. A total of 1061 patients were 
under treatment, of which three hundred and eighteen (30%) patients had at least one main ADR. 
The pattern of important ADR includes Hepatitis 148 (13.9%), GI (nausea/vomiting/GI upset) 
106 (10.0%), Rash 80 (7.5%), Weakness/fatigue 39 (3.7%), Joint pain 34 (3.2%), Visual 
disturbances 18 (1.7%), Anorexia/weight loss 10 (0.9%), and Abdominal pain 9 (0.8%). The 
study concluded that first-line anti-tuberculosis drugs are associated with considerable ADRs. 
There are a number of risk factors colligated with the development of ADRs and  more focus 
needs to be paid to the development of effective, safe and affordable pharmaceutical treatments. 
 
Yee D etal.,
39
 conducted a study to evaluate the incidence of ADRs from first-line anti 
tuberculosis drugs among patients treated for active Tuberculosis at a Chest Institute (Montreal, 
Canada) between 1990 and 1999. It was found that skin rash, hepatitis followed  
by GI disturbances were the major ADRs for ATT. One of the major conclusions of this  
study is the occurrence of pyrazinamide induced skin irritation and toxicity of the liver during 
treatment for active TB was significantly greater than the other first-line ATT. 
 
Koay TK
40
 performed a multistage random sampling methodological study in a selected 
community in the district of Kudat, Sabah to evaluate their knowledge about TB. From 210 
selected houses, 205 respondents were interviewed using a standardized questionnaire to assess 
their knowledge and attitude towards tuberculosis. The study indicates that the knowledge about 
TB were poor among the people in the community. At last the author‟s promoted that health 
education, health activities and training to both health care workers and to the patients were 
necessary for a better treatment outcome. 
 
Mary DB et al.,
41
 examined the impact of health education and counseling on the 
decision of a patient infected with tuberculosis to complete a regimen of INH chemoprophylaxis 
for 6 months to prevent TB. 40 patients were divided into two groups; both groups were 
administered a questionnaire to collect demographic data and medical history. Additional health 
education and counseling was received by one group independent of clinic staff, and the second 
group only received health education and counseling from clinic staff. The proportion of patients 
in the first group who completed isoniazid for 6 months (63.6%) was significantly greater than 
the proportion of patients in the second group (11.1%). These data proving that health education 
and counseling did make an effect on the decision of a patient infected with TB to conform to a 
rational choice when provided with supportive and informative relationship about the 
consequences of TB infection. 
 
Frederick ADK etal.,
42
 made a study in Ndola, Zambia, to investigate factors leading to 
treatment non compliance and awareness of TB transmission among patients during TB 
treatment, in order to propose a community-based intervention that could promote adherence. A 
household based survey was conducted in 6 randomly selected catchment areas of Ndola. Four 
hundred out of seven thirty six patients getting TB treatment within the 6 months period were 
included in the study. All patients were interviewed with the help of a pre-tested structured 
questionnaire. Overall, 29.8% of the patients were dropped out of the anti TB treatment. The 
major factors leading to noncompliance included patients beginning to feel better (45.1%  (male) 
and 38.6% (female)), unawareness on the benefits of adhering to a treatment course (25.7%), 
finishing of drugs stock at home (25.4%) and anti-TB drugs too tough (20.1% and 20.2%). The 
results in this study showed that, when they started feeling better, approximately 39.8% of all TB 
patients did not adhere to their treatment regimen.  
 
To determine compliance, attitude and knowledge with TB treatment by Pulmonary TB 
patients, Mweemba P et al.,
43
 done a descriptive study at a tertiary hospital in Lusaka, Zambia. 
An interview schedule comprising of four sections (compliance, knowledge, demographic, and 
attitude) were used to collect data. A total of one hundred and four respondents aged 18 to 66 
years were enrolled in the study. About half of the respondents (49%) had normal awareness of 
TB treatment. The implication of study is that there is a call for for health care workers to better 
understand the attitude of each patient, peculiarly those that influence adherence and to take 
these into consideration when creating teaching strategies to enhance assimilation of information. 
This study correlated that when the knowledge about ATT is high; it shows a good or positive 
attitude which in turn helps to increase the compliance.  
 
Imran AS et al.,
44
 assessed the prime reasons for premature discontinuation of anti-
tuberculosis therapy by conducting a descriptive cross-sectional study on 200 diagnosed patients 
with PTB at Dept of Chest Medicine, Mayo Hospital, Pakistan. The study showed that among the 
200 patients, 44 (22%) discontinued anti-tuberculosis therapy for various reasons. Poverty, 
feeling of being cured, use of alternative medicine and local remedies were the most frequent 
cause for discontinuation of anti-tuberculosis therapy. This study analyzed that the prime reasons 
for non-compliance with ATT must be addressed immediately by instituting awareness programs 
regarding ATT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
                                      
                         Objective 
 
 
 
OBJECTIVE OF THE STUDY 
 
To study the effectiveness of knowledge based approach for the improvement of patient 
adherence and reducing the severity of adverse drug reaction in anti tubercular therapy in the 
pulmonology department of an 800 bedded super specialty hospital at Coimbatore. 
 
  
  
 
 
 
                       
                   Methodology 
 
 
METHODOLOGY 
STUDY DESIGN: It is a prospective observational study 
STUDY CRITERA:-  
INCLUSION CRITERIA:-Both in patients and outpatients who received the treatment 
for Anti Tubercular Therapy and aged between 16 to 75 years.  
EXCLUSION CREITERIA:- 
• Patients who referred to their nearest clinic or physician for continuation of the treatment 
after diagnosing from the present study site. 
• Patient with MDR TB. 
• Psychologically ill patients. 
• Patient with co-morbidity.  
DURATION OF STUDY:-  
• Six months. 
STUDY SITE:-Department of Pulmonology, Kovai Medical Center and Hospital, 
Coimbatore. 
STUDY POPULATION:-  
• All Patients who are diagnosed with TB and aged between 16 to 75 years. 
STUDY PERIOD: Study conducted over a period of 6 month from July-December 
2011. 
STUDY TOOLS USED:  
•  A self prepared data entry form of the patient. 
•  A patient information pamphlet which was evaluated and validated by the physicians. 
This is the main study tool for this study, which is particularly prepared for understanding 
the seriousness of the ADR by the patient. The pamphlet provide the information's on 
TB, possible ADR during ATT and the emergency contact number of both the physician 
and pharmacist to report ADR by the patient itself once if they suspect the ADR.  
• A knowledge evaluating questionnaire prepared on the basis of patient information 
pamphlet.  
 
DRUG REGIMEN: -   
Intensive phase drug regimen mainly comprises of Rifampicin (R), Isoniazid (INH), 
Pyrazinamide (P), and Ethambutol (E). Streptomycin and levofloxacin were also added to 
the initial treatment regimen whenever necessary. The dosages of the drugs were:  
Rifampicin (150/450/600mg), Pyrazinamide (400/750mg), Ethambutol 
(275/800/1000mg), Isoniazid (75/300mg) and Levofloxacin (750mg). Pyridoxine 
(20/40mg) was integrated in all prescriptions to lessen the incidence of peripheral 
neuropathy.  
 
STUDY DESIGN AND ITS OPERATIONAL MODALITY: -  
Educational module  
A well experienced and skilled pharmacist meticulously educated the tuberculosis patient 
regarding the disease, duration of the treatment, importance of treatment completion and 
about possible adverse effects by using the pamphlet. The patient information pamphlet 
which consists of information concerning possible ADRs and the contact numbers to 
report ADR were given to the patient during the time of counseling itself.  Ultimately the 
pharmacist enables the patient to screen the ADR during the treatment and how to tackle 
them. The knowledge was evaluated after the counseling for analyzing the knowledge of 
the patient regarding his treatment. And re-counseling was performed if it is necessary.    
 
 
Review module  
Patients were informed to check their LFT (SGPT and Total bilirubin), once every 15 
days of two months and to come for review. Proper follow up of the patient were noticed 
during the review period and occurrence of ADR get monitored for the first 2 months of 
therapy.  
 
First review:  15th day after discharging from the hospital. For some patients, physician 
will propose to come before the normal review in accordance to the disease condition.  
 
Second review: 15
th
 day after the second review 
 
 
Third review: 30
th
 day after the second review. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
   Results & Discussions 
 
RESULTS AND DISCUSSIONS 
The study was carried out in the pulmonology department of Kovai Medical Center and 
Hospital at Coimbatore, over a period of 6 months from July to December 2011. A total of 60 
patients were incorporated in the study. Of the whole population 50 (83%) were inpatients and 
10 (17%) were outpatients [Tab 1, Fig 1]. Among the total population, 50 (83%) were male and 
10 (17%) were females [Tab 2, Fig 2]. It is found that males were more prone to tuberculosis 
when compared to females with a ratio of 8:2. A study conducted by Mahmood I et al., reveals 
that the pervasiveness of tuberculosis is more in males than females with a ratio of 5:1. Also the 
NTP summarized as the ratio of the occurrence of TB between the male and female were 5:2.
3
   
One of the study performed by Jaggarajamma K et al., has the identical outcome alike to ours in 
case of the gender wise occurrence of the TB, which contributes that a 7:2.5 ratio of male and 
female incidence of TB.
10   
Not only these studies some other studies also point out that the TB is 
more prone to male gender.
13,21,22,38.
 
The mean age of the study population was found to be 46.63±11.45. Previous data 
regarding the age group who were more prone to TB shows different conclusions. According to 
RNTCP status report (TB India 2006) TB affects habitually in young adults with an age range of 
25-34.
45 
A review through some other studies also reveals the same.
1 
A descriptive study 
executed by Habib-ullah K et al., reveals that the mean age group for TB occurrence is 
42.10±20.38.
22
  The mean age of the TB patients from the study population of Marra F et al., 
were also found to be 49.9±20.
38
 Both of these two studies were supporting to the current study 
outcome. Age group analysis of entire population in our study shows that the most prominent 
group was „46-60‟ comprising of 27 (45%) patients followed by „31-45‟ which comprises about 
15(25%) patient. Age group analysis of male and female patients demonstrated that, 24(48%) 
male patients and 5(50%) female patients fit in to the age range of 46-60 and 31-45 
respectively.[Table 3; Fig 3A,3B & 3C] Over all the study shows that the most prominent age 
group for the occurrence of TB was 40-60, as which is proved by the preceding studies. 
Out of the study population, 35(58%) patients were having the smoking habits [Tab 4, 
Fig 4]. Among the total population, 53(88%) were married.[tab 6, fig 6]. Summarized forms of 
TB diagnosis of our study were illustrated in table [6] and figure [6]. 57(95%) patients were 
diagnosed as pulmonary TB in our study population. About 92% of the populations in the 
research of Jaggarajamma K et al., were diagnosed as PTB.
10
 A study reported by Habib-ullah K 
et al.,
 22
 interpret that 73% of the study population were diagnosed as PTB which was matching 
to our study. Of the remaining patients in our study, 1(1.6%) patient was found to have silico TB, 
1(1.6%) patient was found to have brain TB and 1(1.6%) patient was found to have TB pleural 
effusion. It shows that when compared to EPTB, PTB shows most occurrences as per the prior 
study conclusions. It shows that when compared to EPTB, PTB shows most occurrences as per 
the prior study conclusions.
10,21,22 
Out of the total study population, all the 60 (100%) patients showed the symptom of 
persistent cough for many days followed by fever for 25 (41.66%) patients, haemoptysis for 
17(28.33%) patients, weight lose for 13(21.66%) patients, cold for 4 (6.66%) patients, chest pain 
for 3(5%) patients and breathlessness for 2 (3.33%) patients. [Tab 7, Fig 7] Some of these are the 
cardinal clinical features of PTB such as chronic cough, weight lose, haemoptysis and night 
sweat. About 83.6% of patients were having cough and weight lose in the study done by Bello SI 
and Itiola O A.
1 
Some of the other studies also shows that the patients suffer from the cardinal 
signs and symptoms of TB
2,39,40 
Evaluation of the knowledge concerning the information‟s in 
pamphlet after the primary counseling shows that out of 60 patients, 53 (88%) patients were 
answered correctly [Tab8, Fig 8]. Remaining 7 (12%) patients were not answered correctly and 
who were re-counseled. The patients demonstrated a high level of knowledge of their medication 
regimens, which illustrates the benefit of additional support provided by pharmacists.
35 
Among the full population 60(100%) patients came for the first review 58(96.60%) 
patients came for the second review and 54(90%) patients came for the third review.[Tab 9, Fig 
9] According to study by Susanne Moadebi etal..
18
,
 
the reasons for poor adherence are 
multifaceted and complex, and include lack of knowledge about medications and their side 
effects. Pharmacists who dispense antituberculosis medications provide counselling to enhance 
patient‟s understanding of why they are taking the medication and the potential side effects of 
treatment, thereby helping to ensure patient adherence. Patients expressed greater satisfaction 
with the information about medication side effects that was provided by pharmacists, and there 
was a trend toward greater satisfaction with information about side effect management provided. 
Another study by Frederick ADK etal.,
42
 concluded that 29.8% of TB patients failed to comply 
with TB drug taking regimen once they started feeling better where as in our study we found that 
about 10% of patients failed to continue the proper follow up.  
Among the total population of the study 40 (66.66%) patients were either illiterate or 
having primary education where as 20 (33.33%) patients were having above primary education. 
[Tab 10, Fig 10] No association of review pattern and the literacy levels of the patients in our 
study. In this study the review pattern by the patients was more or less equal in the literate and 
illiterate population. A study conducted by Anupa K C etal.,
15
 also shows the similar result 
where there is no significant relation between the educational level of the patients and review 
patterns. There are further more studies showing similar results.
2, 9, 40, 41, 42
 
In our study, the patients were categorized in four different groups with High, Above Average, 
Average and Poor living standards consisting 5,6,24 and 25 patients respectively having 
100%,83%,87% and 92% of review patients in the third review.[Tab 11, Fig 11A,11B,11C] In 
this it is clear that the patients from high living standards and poor living standards are more 
adherence with the TB treatment. Even though, the difference is very small when compare to 
other two groups. Unlike the study by Munro S A etal., 
14 
 where as the study by Mahmood I et 
al., clearly says that Most of the patients are from low socioeconomic class. It supports 
malnutrition to be a risk factor for tuberculosis. 
3
 
Among the full population 15 (25.00%) patients experienced at least one ADR during the 
time of study period [Tab 12, Fig 12]. The prevalence of ADR occurrence as per three different 
studies (Mahmood I et al., Marra F et al., Anupa KC et al.,) during the intensive phase of ATT 
were found to be 22%, 30%, and 55%.
3, 15, 38
 Out of 15 ADR victims 14 (93%) were male and 1 
(7%) was female [Tab 13, Fig 13]. Majority of them were males and the statistically there is no 
significant relation between the occurrence of ADR and gender.
15, 21
 The most prone age group 
for ADR incidence was found to be “46-60” group comprising of 11(73.33%) patients[Tab 14, 
Fig 14].. This result is controversial to the study of Anupa KC et al., in which the most 
prominent age group for the occurrence of ADR for ATT were belongs to “21-30” group. The 
statistical result shows that there is no significant relationship between the age and ADR which is 
similar to the previous study.
15
  
A total of 16 ADRs have been reported by these 15 patients with one patient developing 
two ADRS nausea and chest pain by the end of first month of ATT. Out of 16 ADRs 6(37.50%) 
were elevated liver enzyme/vomiting, which is most prominent followed by chest pain with 
3(18.75%) patients [Tab 15, Fig 15]. Drug induced liver problem is not a rare problem in ATT. It 
is seen that a 20% hepatotoxic ADR victims in the study of Khalid M et al.,
21
 Previous studies 
proved that liver and biliary system and gastro intestinal system were the most frequent organ 
system for the development of ADRs for anti tubercular drugs.
1,20,21,22,38,
 It shows that hepatitis 
followed by the vomiting were the major ADRs occurred in the population of the study of Marra 
F et al., which is similar to our study.
38
  
The time interval between start of therapy and onset of ADR is given in the table [Tab 16, 
Fig 16]. It was found that 10 (67%)  ADRs occurred within the first visit after starting the 
therapy. An overview of the table [16] and graph [16] shows that as there is a decreased 
incidence of ADRs when the days get increased. This is quite similar to the study of Kheirollah 
G et al.,
23
   
The ADR victims and the review pattern by those patients is given in Tab [17] and Fig 
[17] which shows that the percentage of drop out patients from the ATT before the third review 
is more[13.33%] when compare with that of total population with [10%] of patients fails to 
adhere with the ATT by the completion of intensive phase. Even in the study by Munro S A etal.,
 
also reveals the same, the influence of side effects on adherence to treatment was mentioned in a 
number of studies some patients reported stopping medication because of adverse effects, while 
others reported that they were not informed about side effects and what to do to counter them, 
patients acknowledged that side effects had inﬂuenced their decision to abandon treatment. 14 
Even other studies also agree with the point that side effects of the anti-tuberculosis agents have 
negative impact on patient‟s drug adherence.1,9,10, 
 At the end of two month follow up of the study it was found that total 6 (10%) patients 
were dropped out of the study during the intensive phase of ATT due to non compliance. The 
locality wise distribution and review pattern of patients who were enrolled in our study is given 
in Tab [18], Fig [18]. From the table it is clear that patients who are from a very distant place are 
more prone to drop out of the ATT than one staying near to the clinic. It is very similar to the 
study conducted by Erhabor G E et al., 
7 
who says that the patients lived within 25 km is more 
adherent than others who lived in distant place. It was observed that 54 (90%) patients were 
adhered to treatment till the completion of intensive phase, which is a great level of adherence 
and this is directly related to the knowledge based approach and the good communicative patient 
care system in our study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
          Tables and Graphs 
 
 
 TABLES AND GRAPHS 
 
TABLE 1: WARD WISE DISTRIBUTION OF TOTAL PATIENTS (n=60) 
 
 
Type of patient Frequency Percentage 
Inpatient 50 83% 
Out patient 10 17% 
Total 60 100% 
 
 
 
 
 
 
 
 
 
 
FIGURE 1: WARD WISE DISTRIBUTION OF TOTAL PATIENTS 
(n=60) 
 
 
 
 
83%
17%
IP PATIENTS
OP PATIENTS
  
 
 
 
 
TABLE 2: GENDER WISE DISTRIBUTION OF TOTAL PATIENTS (n=60) 
 
 
Gender Frequency Percentage (%) 
Males 50 83% 
Females 10 17% 
Total 60 100% 
 
 
 
 
 
 
 
 
 
 
FIGURE 2: GENDER WISE DISTRIBUTION OF TOTAL PATIENTS 
(n=60) 
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TABLE 3: AGE WISE DISTRIBUTION OF PATIENTS 
 
 
 
 
 
 
 
 
FIGURE 3A: AGE WISE DISTRIBUTION OF TOTAL PATIENTS (n=60) 
Age group Total frequency (%) Male frequency (%) Female frequency (%) 
16-30 11(18%) 10(20%) 1(10%) 
31-45 15(25%) 10(20%) 5(50%) 
46-60 27(45%) 24(48%) 3(30%) 
61-75 7(12%) 6(12%) 1(10%) 
Total 60(100%) 50(100%) 10(100% 
 
 
 
 
 
 
 
 
FIGURE 3B: AGE WISE DISTRIBUTION OF MALE PATIENTS (n=50) 
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FIGURE 3C: AGE WISE DISTRIBUTION OF FEMALE PATIENTS (n=10) 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 4: SMOKING HABITS IN TOTAL PATIENTS (n=60) 
 
 
Smoking habit Number of patients Percentage (%) 
Smokers 35 58% 
Non smokers 25 42% 
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FIGURE 4: SMOKING HABITS IN TOTAL PATIENTS (n=60) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 5: MARITAL STATUS OF THE PATIENTS 
 
STATUS No of patients Percentage (%) 
Married 53 88% 
Single 7 12% 
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FIGURE 5: MARITAL STATUS OF THE PATIENTS 
 
 
 
 
 
 
 
 
 
TABLE 6: TYPES OF TUBERCULOSIS DIAGNOSED (n=60) 
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Diagnosis Frequency Percentage (%) 
Pulmonary tuberculosis 57 95% 
Silico TB 1 1.6% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6: TYPES OF TUBERCULOSIS DIAGNOSED (n=60) 
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 \ 
 
TABLE 7: SIGNS & SYMPTOMS 
 
 
SIGNS & SYMPTOMS NO OF PATIENTS 
breathlessness 2 
chest pain 3 
cold 4 
wt lose 13 
Haemoptysis 17 
Fever 25 
Cough 60 
 
 
 
 
 
 
 
 
FIGURE 7: SIGNS & SYMPTOMS 
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TABLE 8: COUSELING STATUS OF THE PATIENTS (n=60) 
 
 
 
Counselling status frequency Percentage (%) 
Patients who were not re-counseled 53 88% 
Patients who were re-counseled 7 12% 
 
 
 
 
 
 
 
FIGURE 8: COUSELING STATUS OF THE PATIENTS (n=60) 
 
 
 
 
 
 
 
 
TABLE 9: REVIEW PATTERN OF THE PATIENTS (n=60) 
 
 
First review 100%(60) 
 
Second review 
 
96.60%(58) 
 
Third review 
 
90%(54) 
 
 
 
 
53
7
0
10
20
30
40
50
60
Patients who were not re-counseled Patients who were  re-counseled
F
re
q
u
en
cy
patients
Re-counselling
  
 
FIGURE 9: REVIEW PATTERN OF THE PATIENTS (n=60) 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 10: LITERACY LEVEL OF THE PATIENTS (n=60) & REVIEW PATTERN 
 
 
 
EDUCATION FREQUENCY 3
RD
 REVIEW 2
ND
 REVIEW 1
ST
 REVIEW 
Primary 
 
27 26 0 1 
Secondary 
 
7 5 2 0 
   Degree 
 
8 7 0 1 
100%
96.60%
90%
First review
Second review
Third review
   Masters 
 
5 5 0 0 
   Nil 
 
13 11 2 0 
 
 
 
 
 
FIGURE 10: LITERACY LEVEL OF THE PATIENTS (n=60) & REVIEW PATTERN 
 
 
 
 
 
 
 
 
 
 
TABLE 11: LIVING STANDARED OF THE PATIENTS (n=60) 
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FIGURE 11 A: LIVING STANDARED OF THE PATIENTS (n=60) 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 11 B: LIVING STANDARED OF THE PATIENTS & REVIEW PATTERN (n=60) 
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FIGURE 11 C: LIVING STANDARED & PERCENTAGE OF 3
RD
 REVIEW (n=60) 
 
 
 
 
TABLE 12: DISTRIBUTION OF PATIENTS WHO DEVELOPED ADR (n=60) 
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FIGURE 12: DISTRIBUTION OF PATIENTS WHO DEVELOPED ADR (n=60) 
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TABLE 13: GENDER WISE DISTRIBUTION OF ADR VICTIMS (n=15) 
 
 
GENDER FREQUENCY PERCENTAGE 
MALE  14  93% 
FEMALE 1 7% 
 
 
 
 
 
 
 
 
 
 
FIGURE 13: GENDER WISE DISTRIBUTION OF ADR VICTIMS (n=15) 
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TABLE 14: AGE WISE DISTRIBUTION OF ADR VICTIMS (n=15) 
 
AGE group Frequency 
16-30 2 
31-45 1 
46-60 11 
61-75 1 
 
 
 
 
 
 
FIGURE 14: AGE WISE DISTRIBUTION OF ADR VICTIMS (n=15) 
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TABLE 15: TYPES OF ADR DEVELOPED (n=16) 
 
TYPE OF ADR FREQUENCY 
 
Abdominal pain 
1 
 
 
Breathlessness 
1 
 
Chest pain 
3 
 
Giddiness 
1 
 
Nausea 
1 
 
numbness of feet 
1 
 
Skin rashes 
2 
 
Vomiting/elevated liver enzyme 
6 
 
 
 
 
 
FIGURE 15: TYPES OF ADR DEVELOPED (n=16) 
 
 
 
 
 
 
 
TABLE 16: DEVOLEPMENT OF ADR (n=15)(%) 
 
1
ST
 VISIT 10(67%) 
2
ND
 VISIT 4(26%) 
3
RD
 VISIT 1(7%) 
 
 
 
 
 
 
FIGURE 16: DEVOLEPMENT OF ADR (n=15) 
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TABLE 17: ADR VICTIMS AND REVIEW PATTER (n=15) 
 
 
 
 
ADR VICTIMS 
 
FREQUENCY PERCENTAGE (%) 
Total ADR victims 
 
15 
  
100% 
ADR victim came for 3rd review 
 
13 
 
86.67% 
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FIGURE 17: ADR VICTIMS AND REVIEW PATTERN 
 
 
 
 
 
 
 
 
TABLE 18: LOCALITY WISE DISTRIBUTION OF THE PATIENTS (n=60) & REVIEW 
PATTERN 
 
AREA Total 3rd 
review 
2nd 
review 
1st 
review 
Coimbatore/thirupur/palladam/pollachi 
 
22 21 0 1 
Erode/ooty 
 
10 10 0 0 
12
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15
Total ADR victims ADR victim came for 3rd 
review
15
13
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ADR VICTIMS
Salem/namakkal/villupuram/dindigul/dharmapuri/kannanur 
 
28 23 4 1 
 
 
 
FIGURE 18: LOCALITY WISE DISTRIBUTION OF THE PATIENTS (n=60) & REVIEW 
PATTERN 
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  SUMMARY & CONCLUSION 
 
 
 
 
SUMMARY AND CONCLUSION 
A well communicated health care team work study was performed in the department of 
pulmonology at Kovai Medical Center and Hospital, Coimbatore. This study was principally 
emphasized in absolute care of tuberculosis patients throughout their intensive phase therapy by 
providing a knowledge based approach to improve the drug adherence and reducing the severity 
of adverse drug reaction. 
A patient information pamphlet named as “THINGS TO BE NOTICED WHILE 
TAKING MEDICINES FOR TUBERCULOSIS” was already prepared which was used in the 
current study which includes the essential information regarding therapy, possible ADRs during 
the ATT and the emergency number to contact in case of any emergency due to adverse drug 
reactions or to take prior booking for the next review. A well experienced and skilled pharmacist 
counseled the patients with the help of scheduled pamphlet and enables the patients to adhere 
with the ATT and deal with the possible ADRs.  
Entirely 60 patients were included in our study. Tuberculosis was predominant in males. 
Our study found that TB occurred chiefly in age group of “46-60”. Majority of them had PTB. 
Most of the patients needed hospitalization (83%) during the initial phase of the study. A total of 
58% patients had smoking habit which could be a result of increasing the risk of infection with 
TB mycobacteria in these individuals. Smoking can decrease the immunity or damage the 
functioning of cilia in the airways which may increase the risk of getting infected easily.  
Most of the patients were presented with cardinal signs of TB such as cough, 
haemoptysis and weight lose. In our study all the patients got the counselling from the well 
experienced clinical pharmacist with the help of a pamphlet and the knowledge was assessed by 
giving them a knowledge evaluation questionnaire. And 7 patients who failed to answer properly 
were re-counseled by the clinical pharmacist. So that they could understand the treatment 
properly and adhere to ATT.  
A total of 60 patients that is entire population came for the first review and 50 (90%) 
patients came for the third review which is a very good response from the patients still to achieve 
full adherence further possible steps should be taken. Out of 60 patients 40 were having no 
education or a primary education where as rest of the patients were well educated. However no 
significance was found between education and review pattern of the patients in our study. 
Living standard of the majority of the patients were found to be poor or average which 
could be a reason for getting infected by the TB mycobacteria as they may be undernourished, 
increasing the rate of active TB.  Where as when comparing the review pattern by these patients 
it was found that the patients with high living standard have 100% adherence with ATT who 
came for all the three review during the intensive phase of treatment.  
A total number of 16 ADRs were reported by 15(25%) patients with one patient reported 
with two ADRs.  It was found that hepatic biliary system were the major spot for the incidence 
of ADR. It showed that 67% of ADRs occurred within the 15 days of ATT and day by day the 
incidence of ADRs was decreasing.  Occurrence of adverse effects or unawareness about how to 
deal with the ADRs may influence the patients from stopping the ATT and finally the occurrence 
of drug resistance. There plays the role of a pharmacist where he can implement a good patient 
care by providing information about the treatment and possible ADRs and what to do if any of 
them is suspecting. As a pharmacist, we have the liability to support the patients during the 
periods of ATT, while they were suffering these kinds of unwanted effects of the drug. 
Amplified healthcare cost.  If a proper educational system is implemented like our study, most of 
the patients were ready to adhere with the treatment with 90% of adherence and there by 
increasing the therapeutic outcome.  
In our study totally 6(10%) patients were dropped out of intensive phase of the ATT out 
of which majority were living very far from the study center. So it is clear that that patient who 
stays near to the clinic shows more compliance with ATT.  
A good constitutional system of communicational approach to the patient by group effort of the 
pharmacist and physician with the aim of complete patient care will aid for early detection of the 
ADRs of any drug and can trim down the incidence and severity of the same. Since DR is the 
major emerging problem during ATT, implementation of well communicated system like 
pharmacist counselling will help to hoist the patient‟s self-assurance in the treatment and reduced 
incidence of DR.  
 One recommendation of this study is to implement a new-fangled call system along with 
knowledge based approach by a pharmacist, which alarms the patient to come for the next review 
in right time for a better adherence. 
In this prospective observational study, it is suggested that the clinical pharmacist should 
exhibit their vital role during TB therapy in TB centers, pulmonology departments and DOTS 
centers to guarantee a better patient therapeutic outcome.   
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                        Annexures 
 
                                               PATIENT DATA ENTRY FORM 
 
                                             
IP/OP No:                                                       Name:  
 
Date of admission:                                              Address:   
 
Date of discharge:   
 
Age:                               Gender:  
 
Occupation:                                                                Educational status:  
 
Marital status:                                                           Smoking: -   Y           N  
 
Diagnosis:-   
 
Prescribed medications:  
 
          
No 
Drug Dose Frequency Duration 
 
     
     
     
     
     
     
Review details                                                           ATT started on 
Review  
Number 
 
Date Review details  
 
   
   
   
   
   
 
ADR Reporting details:  
No Reported ADR Date Notes  
 
    
    
    
 
  
 
 
 
  
  
   
 
 
PATIENT INFORMATION PAMPHLET (TAMIL)
 
 
PATIENT INFORMATION PAMPHLET (ENGLISH) 
 
 
 
